A randomized, double-blind, placebo-controlled, parallel-group study was conducted to
evaluate the efficacy and safety of gabapentin in relieving the symptoms of social phobia. Sixty-…

Background: The anticonvulsant, lamotrigine, may be useful for symptom management in
PTSD. Methods: Subjects enrolled in a 12-week double-blind evaluation of lamotrigine and …

BackgroundMost pharmacotherapy trials in post-traumatic stress disorder (PTSD) have been
conducted upon male combat veterans. Outcome studies relating to civilians are therefore …

In this small pilot study, we evaluated quality of life for 16 posttraumatic stress disorder (PTSD)
patients by administering the Medical Outcomes Study 36‐item Short‐Form Health Survey …

Post-traumatic stress disorder (PTSD) increasingly is being recognized as common, often
chronic, and requiring a multidimensional treatment approach. Psychopharmacologic …

The effect of repeat oral doses of ritonavir, at high (600 mg twice daily) and low (100 mg
twice daily) doses, on the pharmacokinetics of a single dose of bupropion was evaluated in …

Although social phobia is thought to be a chronic disorder, little is known about its long-term
course in patients who engage in brief treatment studies. We, therefore, conducted a follow-…

Conclusions: There was little indication of improvement for atomoxetine plus buspirone
versus atomoxetine monotherapy, as most efficacy measures showed only slightly greater …

Purpose: In response to earlier reports that raised concerns about the tolerability of fluoxetine
in the treatment of posttraumatic stress disorder (PTSD), this study was conducted to …

Panic disorder and social phobia are two com-mon anxiety disorders that affect many adults
in the United States today. It has been estimated that 3.5% of adults in the United States will …